Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
33.32
+2.64 (8.60%)
At close: May 12, 2025, 4:00 PM
34.98
+1.66 (4.98%)
After-hours: May 12, 2025, 6:12 PM EDT
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $3.12 billion as of May 12, 2025. Its market cap has decreased by -7.54% in one year.
Market Cap
3.12B
Enterprise Value
1.90B
1-Year Change
-7.54%
Ranking
Category
Stock Price
$33.32
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $3.12B, an increase of 453.52%. That is a compound annual growth rate of 28.55%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |